These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29316555)

  • 1. Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.
    Naito Y; Kashiwagi K; Takagi T; Andoh A; Inoue R
    Digestion; 2018; 97(2):195-204. PubMed ID: 29316555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.
    Macke L; Schulz C; Koletzko L; Malfertheiner P
    Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
    Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications.
    Le Bastard Q; Al-Ghalith GA; Grégoire M; Chapelet G; Javaudin F; Dailly E; Batard E; Knights D; Montassier E
    Aliment Pharmacol Ther; 2018 Feb; 47(3):332-345. PubMed ID: 29205415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection.
    Lin CY; Cheng HT; Kuo CJ; Lee YS; Sung CM; Keidan M; Rao K; Kao JY; Hsieh SY
    Microbiol Spectr; 2022 Aug; 10(4):e0048622. PubMed ID: 35863023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
    Weitsman S; Celly S; Leite G; Mathur R; Sedighi R; Barlow GM; Morales W; Sanchez M; Parodi G; Villanueva-Millan MJ; Rezaie A; Pimentel M
    Dig Dis Sci; 2022 Jan; 67(1):224-232. PubMed ID: 33534012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of proton pump inhibitors on the microbiome in young children.
    Levy EI; Hoang DM; Vandenplas Y
    Acta Paediatr; 2020 Aug; 109(8):1531-1538. PubMed ID: 32027402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection.
    Khanna S; Montassier E; Schmidt B; Patel R; Knights D; Pardi DS; Kashyap P
    Aliment Pharmacol Ther; 2016 Oct; 44(7):715-727. PubMed ID: 27481036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
    Hojo M; Asahara T; Nagahara A; Takeda T; Matsumoto K; Ueyama H; Matsumoto K; Asaoka D; Takahashi T; Nomoto K; Yamashiro Y; Watanabe S
    Dig Dis Sci; 2018 Nov; 63(11):2940-2949. PubMed ID: 29796911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.
    Paroni Sterbini F; Palladini A; Masucci L; Cannistraci CV; Pastorino R; Ianiro G; Bugli F; Martini C; Ricciardi W; Gasbarrini A; Sanguinetti M; Cammarota G; Posteraro B
    Appl Environ Microbiol; 2016 Nov; 82(22):6633-6644. PubMed ID: 27590821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the effects of proton pump inhibitors on the small intestine?
    Fujimori S
    World J Gastroenterol; 2015 Jun; 21(22):6817-9. PubMed ID: 26078557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis.
    Horvath A; Rainer F; Bashir M; Leber B; Schmerboeck B; Klymiuk I; Groselj-Strele A; Durdevic M; Freedberg DE; Abrams JA; Fickert P; Stiegler P; Stadlbauer V
    Sci Rep; 2019 Aug; 9(1):12000. PubMed ID: 31427714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
    Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
    World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Frémont M; Coomans D; Massart S; De Meirleir K
    Anaerobe; 2013 Aug; 22():50-6. PubMed ID: 23791918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure.
    Roychowdhury S; Cadnum J; Glueck B; Obrenovich M; Donskey C; Cresci GAM
    JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1156-1167. PubMed ID: 29385239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.
    Castellani C; Singer G; Kashofer K; Huber-Zeyringer A; Flucher C; Kaiser M; Till H
    Front Cell Infect Microbiol; 2017; 7():444. PubMed ID: 29075620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice.
    Takashima S; Tanaka F; Kawaguchi Y; Usui Y; Fujimoto K; Nadatani Y; Otani K; Hosomi S; Nagami Y; Kamata N; Taira K; Tanigawa T; Watanabe T; Imoto S; Uematsu S; Fujiwara Y
    Neurogastroenterol Motil; 2020 Jul; 32(7):e13841. PubMed ID: 32319196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
    Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.